The Russian healthcare regulator has summarized the results of its internet monitoring efforts. Last year, Roszdravnadzor identified thousands of violators and referred the data to Roskomnadzor for access restriction. The total number of blocked sites since the campaign began has exceeded 117,000.
The Federal Service for Surveillance in Healthcare (Roszdravnadzor) has released data on its fight against illegal online drug sales. Since the monitoring system was launched in September 2020, the agency has analyzed over 176,000 web resources.
Key Figures
- 117,075 websites have been blocked by Roskomnadzor based on Roszdravnadzor’s decisions over the entire observation period (since 2020).
- 21,500 resources ceased operations in 2025 alone.
Main Violations
According to the agency, the primary grounds for blocking decisions are:
- Lack of a pharmaceutical license and permission for remote trading.
- Offers of unregistered, falsified, or substandard medicines.
- Attempts to sell prescription drugs, psychoactive substances, and pregnancy termination medicines, the online sale of which is strictly prohibited.
Cooperation with Marketplaces
Roszdravnadzor highlighted the effectiveness of its cooperation with the Association of Internet Trade Companies (AKIT). A special communication channel has been established for rapid response. This allows aggregators (such as Ozon, Wildberries, etc.) to independently remove product listings that violate legislation immediately upon receiving a signal from the regulator, without waiting for the forced blocking of the entire resource.
